Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
ADC EU — World ADC Berlin 2016
ID
762592
Dates
08 Feb 2016 - 10 Feb 2016
Location
Berlin, Germany
Abstract
Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research. Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.
Contact
Charlotte Parnaby;     Phone: [+44 (0)20 3141 8700];     Email: adc@hansonwade.com
Topics
adc, antibody, drug, conjugate, conjugates, antibody drug conjugates
Related subject(s)
2.
 
Targeted Drug Delivery
ID
749237
Dates
11 Feb 2016 - 12 Feb 2016
Location
Basel, Switzerland
Abstract
2-day masterclass will provide a detailed overview of the newest strategies and achievements in drug delivery and targeting, with particular attention paid to the use of nanoparticles, macromolecules, nucleic acids and small molecule conjugates.
Contact
Andrea Weber;     Email: andrea.weber@flemingeurope.com
Topics
Tagreted drug delivery, Targeting strategies, Drug Development, Nanoparticles, Antibody-Drug conjugates, ADCs, Vaccine delivery, Nanotheranostics, Drug delivery devices, Bio-instrumentation, Nanopharmaceuticals, Magic bullet therapy, Cancer drug targeting
3.
 
RNA 2016 — RNA Therapeutics
ID
748179
Dates
15 Feb 2016 - 16 Feb 2016
Location
London, United Kingdom
Abstract
With a focus on messenger RNA-based therapeutics and anti-sense oligonucleotide-based drugs, the 2016 agenda will tackle the challenge of transporting RNA to target sites outside the liver and optimise bioavailability and kinetics.
Contact
Teri Arri;     Phone: [+44 (0)20 7827 6162];     Email: tarri@smi-online.co.uk
Topics
RNAi, rna therapeutics, delivery systems, drug safety, animal models, cell culture, cell, mrna, clinical trials, immune response, liver, oligonucleotide, ligand, receptor, gene expression, in vitro, in vivo, drug safety, nanotechnology, nanoparticles, cell dianostics, hepatocytes, antibody conjugate, pharmacokinetics, gene silencing, protein, formulation, cgmp, endocytosis, aptamer
Related subject(s)
4.
 
icddt — 7th International Conference on Drug Discovery and Therapy
ID
723296
Dates
15 Feb 2016 - 18 Feb 2016
Location
Dubai, United Arab Emirates
Abstract
The 7th ICDDT will highlight cutting-edge advances in all major disciplines of Drug Discovery and Drug Therapy. This four-day event will feature recent findings from leading industrial, clinical and academic experts in the field, in the form of lectures and posters. The 7th ICDDT will be unique in promoting the translational nature of modern biomedical and pharmaceutical research, with both scientists and clinicians associated with either patient care or with drug discovery research. A number of Nobel Laureates will deliver keynote lectures at the conference. It will bring together leading clinicians, medicinal chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in drug discovery and therapeutics.
Contact
Qasit;     Phone: [(+971-6-5575783)];     Email: marketing@icddt.com
5.
 
Project management tools to improve productivity and compliance in Analytical laboratories
ID
789814
Dates
18 Feb 2016 - 19 Feb 2016
Location
San Francisco, United States
Abstract
The pressure has been mounting in the pharma and biopharma industries in recent years to do more with less. Analytical laboratories are no exception to this trend. Work piles up while personnel have been cut or remain stagnant. Accelerated timelines further strain resources. Constant firefighting and band-aiding results in errors as well as compliance violations. It can be argued that the cost of non-compliance is more than that of compliance.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
project management tools, analytical testing laboratories, Analytical laboratories
6.
 
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
ID
789824
Dates
18 Feb 2016 - 19 Feb 2016
Location
San Francisco, United States
Abstract
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing
7.
 
ADPHaC2016 — 1st Abu Dhabi Pharmacy Conference
ID
784141
Dates
19 Feb 2016 - 21 Feb 2016
Location
Dubai, United Arab Emirates
Abstract
A unique conference bringing together some of the most recognized names in healthcare & pharmacy practice, providing you with the opportunity to advance your practice, gain new knowledge, develop new ideas for your organizations as well network with your peers and experts in the field. Recognizing that learning is best accomplished through an engaging and interactive setting, ADPhaC will also feature several workshops and networking sessions which will give you the chance to meet and interact with field experts and delegates in a casual setting.
Contact
Basil Kadara;     Phone: [97144532975];     Email: contact@diaedu.com
Topics
Pharmacy, Medicine, Pharmacology
Event website
8.
 
LDN 2016 — The LDN 2016 AIIC Conference
ID
725314
Dates
19 Feb 2016 - 21 Feb 2016
Location
Orlando, United States
Abstract
The LDN AIIC 2016 Conference is produced by the LDN Research Trust, a non-profit, Registered Charity dedicated to raising awareness as well as funding research and clinical trials of LDN as a treatment for Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid, Arthritis, Chronic Pain and other auto-immune diseases. The central role of the conference is to review, compare and contrast the most recent LDN-related data and treatments. It also offers compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN to achieve positive, and in many cases, life-changing results.
Contact
Jim Warner;     Phone: [+1 770-663-8803];     Email: jim.warner@ldn2016.com
Topics
LDN, MS, Chrohns, Fibromyalgia, Chronic Pain, Autism, Colitis, ME/CFS
Related subject(s)
Event website
9.
 
G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery
ID
739920
Dates
21 Feb 2016 - 25 Feb 2016
Location
Keystone, United States
Abstract
The field of G protein-coupled receptors has recently seen major advances in high-resolution structure determination, as well as the validation of novel paradigms of drug action, such as allosteric modulation and biased agonism, as likely universal mechanisms. These studies are opening new insights into the diversity of this receptor superfamily, teaching us new lessons in receptor functionality and hinting at novel avenues to investigate. At the same time, we are seeing exciting discoveries in GPCR intracellular signaling and physiology. The timing is right to bring together researchers in these different areas. This Keystone Symposia meeting will focus on the interplay between these discoveries and how they are being used to advance GPCR-based research toward improved clinical outcomes. 
Related subject(s)
10.
 
Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues
ID
789845
Dates
22 Feb 2016 - 23 Feb 2016
Location
Orlando, United States
Abstract
This seminar will guide the attendee in effectively handling, addressing and remediating FDA's and other related compliance issues associated such as FDA's Form 483, Warning Letter and Consent Decree Compliance Findings. An effective handling and resolution of Compliance issues will prevent further disciplinary actions such as an FDA's Warning Letter or a formal Consent Decree which ends with a costly impact, fines and possible injunctions by the FDA.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA Form 483 Warning Letters, FDA Consent Decree, FDA injunction, Code of Federal Regulations, FDA Form 483 Seminar
11.
 
Africa Pharmaceutical Summit
ID
725630
Dates
24 Feb 2016 - 25 Feb 2016
Location
Nairobi, Kenya
Abstract
In its 3rd year, the Africa Pharmaceutical Summit (APS) is now established as the most strategic industry event in the region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing and enhance multi-stakeholder cooperation on issues relating to pharmaceutical sector development in this fast growing region of the world. Building a competitive agenda can have a major influence on investment decisions, and is an ideal platform for the pharmaceutical industry to invest, contributing to the health of everyone living in Africa, and to the local economies. A sophisticated partnership and regular dialogue between industry and government adds value to this agenda. A UNIQUE PLATFORM AND IDEAL MEETING PLACE, IN A FAST GROWING REGION OF THE WORLD, FOR POLICY MAKERS, SENIOR PHARMACEUTICAL AND HEALTHCARE INDUSTRY EXECUTIVES, INVESTORS AND STAKEHOLDERS
12.
 
Ubiquitin Research & Drug Discovery Conference
ID
744930
Dates
24 Feb 2016 - 25 Feb 2016
Location
San Diego, United States
Abstract
Recent breakthroughs in research, such as the phosphorylation of ubiquitin, have exciting implications for drug discovery. This meeting seeks to create a forum for scientists to discuss advances in structural insights, novel drug targets, and other hot topics in ubiquitin-pathway research. Attend this event not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas. 
13.
 
Enzymes in Drug Discovery Summit
ID
744906
Dates
24 Feb 2016 - 26 Feb 2016
Location
San Diego, United States
Abstract
The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.
14.
 
11th Annual Biomarkers Congress
ID
743549
Dates
25 Feb 2016 - 26 Feb 2016
Location
Manchester, United Kingdom
Abstract
Our renowned biomarkers congress showcases world-class speakers discussing novel developments in pre-clinical biomarker research, personalised medicine, clinical research and diagnostics.
Contact
Danielle Dalby;     Phone: [+44 (0)1865 248455];     Email: d.dalby@oxfordglobal.co.uk
15.
 
Patient Adherence and Compliance Masterclass
ID
749592
Dates
25 Feb 2016 - 26 Feb 2016
Location
Amsterdam, Netherlands
Abstract
The pharmaceutical industry is undergoing changes, and is shifting towards patient centricity. innovative outlooks and patient insights bring a new weapon to the battle against established challenges. non-adherence increases medical costs, creates waste in medical spending, multiplies the number of hospitalizations and threatens lives. The issue touches all stakeholders involved in healthcare: from the pharmaceutical companies to doctors to the patients themselves. Therefore, effective improvement is possible only through the cooperation of multiple stakeholders. improve stakeholder collaboration, build lasting relationships, learn about the challenges of others and improve adherence for the benefit of all. Whether you are an industry representative, a medical doctor, a health insurance representative or a member of a patient organization, the Patient adherence and compliance masterclass is the perfect opportunity to join forces with other stakeholders and make progress in improving adherence.
Contact
Andrea Weber;     Phone: [+421257272145];     Email: andrea.weber@flemingeurope.com
Topics
Patient Compliance, Patient Value, Patient Engagement, patient solutions
16.
 
Epigenetic Enzymes in Drug Discovery Summit
ID
744905
Dates
25 Feb 2016 - 26 Feb 2016
Location
San Diego, United States
Abstract
Epigenetic Enzymes in Drug Discovery Summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.  
17.
 
Protease Inhibitors in Drug Discovery Conference
ID
744988
Dates
25 Feb 2016 - 26 Feb 2016
Location
San Diego, United States
Abstract
Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, deubiquitinating enzymes, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
18.
 
Seminar on HIPAA 2016 - Upcoming Changes - Revenue Growth and HIPAA Dangers - Market Vigorously and Comply with HIPAA at New Orleans, LA
ID
774069
Dates
25 Feb 2016 - 26 Feb 2016
Location
New Orleans, United States
Abstract
Paul Hales, with a team of expert advisors and practical field testers, have created a method of making all HIPAA regulations accessible to the everyday person, explained in plain language with exact citations to each regulation for the benefit of the organizations' legal counsel who may not be experienced in HIPAA.
Contact
Event Manager;     Phone: [0800 4479407];     Email: support@globalcompliancepanel.com
Topics
HIPAA 2016, HIPAA Compliance Program, HIPAA enforcement, HIPAA's Privacy, Breach, and Security Rules, HIPAA Risk Analysis
19.
 
Data Management and Statistical Issues with Clinical Trials
ID
782504
Dates
25 Feb 2016 - 26 Feb 2016
Location
Miami, Florida, United States
Abstract
This two-day workshop will be conducted by an industry expert who has wealth of experience managing data in clinical trials. After attending this workshop, you can be rest assured that you will be much better equipped in managing data and statistical issues in a compliant way. The tips that the instructor will share during the course of the training program will be invaluable, regardless of where you are in your career.
Contact
Peter Brown;     Phone: [+1 410-501-5777];     Email: pbrown@fdamap.com
Topics
clinical trial, clinical data management, drug development, clinical trial management
20.
 
Medical Device Risk Management A to Z - Best Practices for Effectiveness and Efficiency
ID
789855
Dates
25 Feb 2016 - 26 Feb 2016
Location
San Francisco, United States
Abstract
The course is designed for Medical Products Manufacturers. The course will be taught for Medical Devices and Combination Products, but will also be of benefit to Pharmaceutical Manufacturers.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
ISO 14971 Training, medical device risk management training, medical device risk management best practices
21.
 
Designing and Sustaining New and Existing Product Stability Testing Program
ID
789810
Dates
25 Feb 2016 - 26 Feb 2016
Location
Orlando, United States
Abstract
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA's Drug Stability Testing Program, NDA submission, 21CFR 514.1(b)(5)(x) expectations, Analytical Testing Considerations
22.
 
How to Prepare for an FDA Meeting: Making the Most of Pre-IND/IDE, pre-NDA and Other Critical Meetings
ID
789919
Dates
25 Feb 2016 - 26 Feb 2016
Location
Washington, United States
Abstract
Despite a few guidance documents to help sponsors prepare for meetings with the FDA, it is a challenge to understand the most efficient and productive ways to strategize, prepare, conduct, and follow-up for these meetings. There are many misconceptions about the expectations from these meetings both for the sponsor and the FDA, and hence many sponsors fail to get the most benefit from them. Over the years, the FDA has also revised processes and practices for meeting with sponsors.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA meeting requirements, FDA meetings planning, FDA meeting stages, FDA meeting guidance, meetings with FDA
23.
 
Statistical Analysis for Process and Product Development
ID
789918
Dates
25 Feb 2016 - 26 Feb 2016
Location
San Francisco, United States
Abstract
This course is designed to help scientists and engineers apply statistical methods used assist decision making in process and product development. Variability must be considered when utilizing data to arrive at conclusions. This course will cover Basic Statistics and Graphical Methods used to summarize data.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Statistical analysis for product development trainings, statistical methods, product development, statistics and graphical methods
24.
 
6th Ubiquitin Research & Drug Discovery Conference
ID
765691
Dates
29 Feb 2016 - 01 Mar 2016
Location
San Diego, United States
Abstract
We are pleased to invite you to GTCbio's 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered.
Contact
Kristen Starkey;     Phone: [16262566405];     Email: infogtcbio@gtcbio.com
25.
 
11th Protein Kinases in Drug Discovery Conference
ID
765789
Dates
29 Feb 2016 - 01 Mar 2016
Location
San Diego, United States
Abstract
We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Phone: [16262566405];     Email: infogtcbio@gtcbio.com
26.
 
Enzymes in Drug Discovery Summit
ID
760822
Dates
29 Feb 2016 - 02 Mar 2016
Location
San Diego, United States
Abstract
We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

Contact
Jessi Huang;     Phone: [16262566405];     Email: jessi.huang@gtcbio.com
Topics
Enzymes in Drug Discovery
27.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
714629
Dates
29 Feb 2016 - 04 Mar 2016
Location
Oxford, United Kingdom
Abstract
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.The module can be taken as a stand-alone short course. It includes group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
28.
 
Pharmacokinetics for Pharmaceutical Scientists Course
ID
725798
Dates
29 Feb 2016 - 04 Mar 2016
Location
San Francisco, United States
29.
 
2nd Protease Inhibitors in Drug Discovery Conference
ID
765808
Dates
01 Mar 2016 - 02 Mar 2016
Location
San Diego, United States
Abstract
We are excited to announce the 2nd Protease Inhibitors in Drug Discovery Conference, which will take place March 1 - 2, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Phone: [16262566405];     Email: infogtcbio@gtcbio.com
30.
 
Epigenetic Enzymes in Drug Discovery Conference
ID
765785
Dates
01 Mar 2016 - 02 Mar 2016
Location
San Diego, United States
Abstract
We invite you to attend the Epigenetic Enzymes in Drug Discovery Conference, which will take place March 1 - 2, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Phone: [16262566405];     Email: infogtcbio@gtcbio.com
31.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
ID
789928
Dates
01 Mar 2016 - 02 Mar 2016
Location
Tampa, United States
Abstract
This interactive one and a half day seminar is intended to help companies understand the legal definitions of cosmetics, drugs, dietary supplements and why certain labeling statements for non-drug products may cause the agency to consider them new drugs without FDA approval.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations
32.
 
Quality Control Laboratory Compliance - cGMPs and GLPs
ID
789894
Dates
03 Mar 2016 - 04 Mar 2016
Location
Tampa, United States
Abstract
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices
33.
 
XVII CONGRESO INTERNACIONAL DE LA ORGANIZACIÓN DE FARMACÉUTICOS IBEROLATINOAMERICANOS y V CONGRESO NACIONAL DE USO RACIONAL DE MEDICAMENTOS
ID
745770
Dates
03 Mar 2016 - 05 Mar 2016
Location
PUERTO VALLARTA, Mexico
Abstract
Evento dirigido a profesionales y estudiantes del �rea de la salud. Tiene como objetivo promover una cultura para el Uso Racional de Medicamentos,  para lo cual hemos reunido especialistas en el �rea de nivel mundial, que  abordar�n temas como seguimiento de la farmacoterapia, mejora en la seguridad del paciente apoy�ndose en la farmacovigilancia, junto con cambios en la atenci�n farmac�utica tanto comunitaria en el primer nivel, como en la especializada en hospitales e instituciones sanitarias. Incluye adem�s, temas orientados con el uso de opioides y f�rmacos en el embarazo y la lactancia.  
34.
 
Antibodies as Drugs
ID
740093
Dates
06 Mar 2016 - 10 Mar 2016
Location
Whistler, Canada
Abstract
Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation. This meeting is being held jointly with  Cancer Vaccines: Targeting Cancer Genes for Immunotherapy.
Related subject(s)
35.
 
CDISC Mapping and Strategies Implemented
ID
789893
Dates
07 Mar 2016 - 08 Mar 2016
Location
Philadelphia, United States
Abstract
CDISC requirements to create SDTMs and ADaMs are not easy to understand or apply. There are many rules and standards that must be mastered and maintained across global studies. Pharmaceutical companies and CROs supporting global studies have a need to apply proven methods that reduce confusion and improve documentation. With new members joining the study team, there should be a system to help standardize and automate the FDA submission process.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
CDISC mapping training, OpenCDISC, CDISC datasets, SDTM, ODM, SDM models, ADAM metadata excel file
36.
 
World ADC Berlin
ID
771740
Dates
08 Mar 2016 - 10 Mar 2016
Location
Berlin, Germany
Abstract
Learn from the industry thought leaders on developing payloads with different mechanisms of action, effectively translating ADCs into the clinic and advancing clinical scale manufacturing.
Contact
Jenny Barlow;     Phone: [44 (0)203 141 8700];     Email: info@hansonwade.com
37.
 
BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry
ID
740193
Start date
09 Mar 2016
Location
Huddersfield, United Kingdom
Abstract
This meeting is aimed at all those who wish to become better drug hunters and heed warnings from the past.
38.
 
2ACPC2016 — 2nd Anti-Counterfeiting Pharma Conference 2016
ID
782912
Dates
09 Mar 2016 - 10 Mar 2016
Location
London, United Kingdom
Abstract
We welcome you to be a part of Recunnect’s 2nd Anti-Counterfeiting Pharma 2016 Conference showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Contact
Sarika Sareen;     Phone: [442071129183];     Email: info@recunnect.com
Topics
Anti-Counterfeiting pharmaceuticals Conferences medicine health drugs drugs safety
39.
 
5th RSC / SCI symposium on Ion Channels as Therapeutic Targets
ID
740236
Dates
14 Mar 2016 - 15 Mar 2016
Location
Cambridge, United Kingdom
Abstract
Ion Channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting ion channels have been discovered for diseases such as hypertension, epilepsy and chronic neuropathic pain, but few were rational designed until recently.
40.
 
New Perspectives for Generic Pharmaceutical Industry
ID
766301
Dates
15 Mar 2016 - 16 Mar 2016
Location
Munich, Germany
Abstract
Participants will systematically evaluate and develop an understanding of the current situation in the generic pharma industry and learn about new strategies and future challenges.
Contact
Andrea Weber;     Phone: [+421 257 272 155];     Email: andrea.weber@fleming.events
Topics
Post patent cliff, Generic industry, Super generics, Innovation, Diferentiation, Sustainable product portfolio, Future of Generics, Pricing of Generics, Regulatory differences in EU
41.
 
Immune Checkpoint Inhibitors 2016
ID
771741
Dates
15 Mar 2016 - 17 Mar 2016
Location
Boston, United States
Abstract
As the frenzy of preclinical and clinical programs continues, it is critical to take a step back and work out what is working and what is not. At this year’s ICI Boston we are gathering the field’s experts to review the latest research and clinical success of checkpoint modulators. With insights and fresh data from early validation through to clinical strategy we’ve curated the most valuable and important case studies from the last 12 months.
Contact
Jenny Barlow;     Phone: [1 212 537 5898];     Email: info@hansonwade.com
42.
 
21st Congress of the EAHP
ID
727585
Dates
16 Mar 2016 - 18 Mar 2016
Location
Vienna, Austria
Abstract
"Hospital Pharmacists taking the lead – partnerships and technologies" will be the theme for the presentations at the Vienna 2016 EAHP Congress. A scientific programme including 3 keynote presentations, 15 seminars EAHP’s Congress is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education, as well as by some of its national member associations according to the different national accreditation systems. open for interactions with the speakers and 6 interactive workshops will offer participants the unique opportunity to meet, network and share expertise. EAHP’s industry partners have also committed to conducting satellite symposia highlighting new developments important to hospital pharmacy.
43.
 
The Second Menactrims Congress — MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis)
ID
742715
Dates
17 Mar 2016 - 19 Mar 2016
Location
Amman, Jordan
Abstract
The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, imaging, epidemiology, differential diagnosis, risk factors, pregnancy, and much more.The congress will convene over a two-day period to present major updates through plenary sessions, scientific symposia and teaching courses. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In addition, the European Charcot Foundation will participate in the meeting for the first time through a scientific symposium.
Contact
Basil kadara;     Phone: [+971 4 453 2975];     Email: contact@diaedu.com
Topics
• Recent advances in MS therapy • MS and the Environment • Update review of MRI in MS • Immunology of MS • Epidemiology of MS • Differential Diagnosis of MS • Update on Secondary Progressive MS • Neuromyelitis Optica • Pediatric MS • MS and pregnancy • Symptomatic Management of MS
Event website
44.
 
INTERNATIONAL CONFERENCE OF PHARMACY AND HEALTH SCIENCES 2016
ID
745949
Dates
18 Mar 2016 - 20 Mar 2016
Location
Ipoh, Malaysia
Abstract
ICPHS 2016 The International Conference of Pharmacy and Health Sciences 2016 (ICPHS 2016) is scheduled on 18-20th March 2016 at Casuarina@Meru, Ipoh, Perak, Malaysia. The conference will feature globally renowned speakers and delegates from academia, research centres and industry to share insights to overcome challenges in the field of Pharmacy Practice (Clinical and Community Pharmacy, Natural Products (Nutraceuticals and Cosmetics), Nanotechnology, Industrial Pharmacy and Education in pharmaceutical sciences. This conference provides an ideal opportunity to researchers, academicians, practitioners, industry players, health professionals, policy-makers and students to upgrade their knowledge by attending various scientific sessions. The Chair and Co-chair look forward to your involvement at this highly anticipated and vital event.
45.
 
HIV Vaccines
ID
740164
Dates
20 Mar 2016 - 24 Mar 2016
Location
Olympic Valley, United States
Abstract
HIV Persistence: Pathogenesis and Eradication. The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.
Related subject(s)
46.
 
Biomarker Summit 2016
ID
744556
Dates
21 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
The Biomarker Summit 2016, to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Oncology Biomarkers, Neurological Biomarkers, Inflammatory & Immunological Biomarkers
Related subject(s)
47.
 
Biomarker Summit
ID
744830
Dates
21 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
The Biomarker Summit is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments.
48.
 
Inflammatory & Immunological Biomarkers Conference
ID
744903
Dates
21 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
This conference will cover both inflammatory and immunological biomarkers in a wide variety of disease areas. The unmet medical needs in autoimmune diseases, respiratory diseases, kidney disease, lupus, IBD and other inflammatory diseases will be discussed. Presentations and case studies from both industry and academia will cover predictive biomarkers, surrogate endpoints and improving clinical trials as it relates to both drug and diagnostic development. This is an opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts in inflammatory and immunological biomarkers. 
49.
 
Neurological Biomarkers Conference
ID
744880
Dates
21 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
This conference focuses on the development of CNS biomarkers for drugs and diagnostics from CSF and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative disorders will be presented on disease areas such as Alzheimer's, Parkinson's and Huntington's. Biomarker challenges for neuropsychiatric disorders such as autism, schizophrenia, depression and mood disorder will also be explored. Attend this event for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts to advance biomarker discovery and development. 
50.
 
Ocular Diseases Drug Discovery Conference
ID
744967
Dates
22 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
Novel therapeutics from the nanotechnology scope are on the rise. The progress in drug and gene-loaded particles that adequately pass through the mucus barriers provides better delivery to ocular tissue. Recent developments in gene therapies with sustained release of a protein have shown promising results with lesser side effects in patients. The event aims to gather leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases. Other hot topics include PRINT® platform for intraocular prostaglandin formulation, coating technology, anti-angiogenic mechanisms and much more!
51.
 
MENAPharExcCong — MENA Pharma Excellence Congress
ID
762684
Dates
28 Mar 2016 - 31 Mar 2016
Location
Dubai, United Arab Emirates
Abstract
The MENA Pharmaceutical Excellence Congress is the premier platform for the pharmaceutical industry and attracts senior local, regional and international leaders from the pharmaceutical industry and government representatives to discuss key issues facing the pharmaceutical industry through a number of interactive presentations, panel discussions and on-stage interviews.

Delegates will have the opportunity to hear from leading experts from across the region and the globe who will discuss the current regulatory environment in the region, key challenges facing the pharmaceutical companies such as pricing, reimbursement and market access, creating successful business models to drive growth for the industry, improving sales and marketing effectiveness by using the latest trends in technologies and creating effective partnership to strengthen relation with the key stakeholders.

Contact
yvette aldeguer;     Email: yvettelourdes5@gmail.com
52.
 
COLD CHAIN — Middle East Pharma Cold Chain Congress
ID
770763
Dates
28 Mar 2016 - 31 Mar 2016
Location
Dubai, United Arab Emirates
Abstract
The Middle East Pharma Cold Chain Congress provides a regional platform that connects industry stakeholders to share their ideas on issues and challenges the industry faces. The congress will bring to fore solutions and strategies that will ultimately ensure healthy shipments and safe pharmaceuticals throughout the region.
Contact
mohammed el shammy;     Phone: [+97143619616];     Email: info@pharmacoldchainme.com
Topics
cold chain
53.
 
Modern Phenotypic Drug Discovery: Defining the Path Forward
ID
743856
Dates
02 Apr 2016 - 06 Apr 2016
Location
Big Sky, United States
Abstract
Innovation and productivity in pharmaceutical drug discovery have been below expectations. Surprisingly, more first-in-class small molecule drugs approved by the FDA (1999-2008) were identified by functional approaches reminiscent of pre-genomics pharmacology (phenotypic drug discovery) than by contemporary molecular targeted strategies. This observation, and the unexpected difficulties of target validation, have diminished the impact of the “genomics revolution” and are arguably associated with the decline in innovation and productivity of pharmaceutical research. As a result, pharmaceutical researchers have begun to reevaluate the “Molecular Mindset” which has dominated our collective drug-hunting culture, and explore modern approaches to phenotypic screening. However, there is currently no single scientific forum where scientists from pharma, biotech, academia and instrument/service providers can meet and discuss strategies/issues related to phenotypic drug discovery (PDD). In part, this is because PDD encompasses multiple therapeutic areas and involves diverse disciplines including drug discovery, chemistry, cell biology, stem cell biology, systems biology, genomics, bioengineering and informatics. This Keystone Symposia meeting uniquely provides this interdisciplinary environment and is a particularly attractive venue given the increasing role of academia in drug discovery research. The conference will be a forum for the global PDD research community in which scientists from diverse institutions and scientific disciplines can meet to share/discuss/debate topics related to advantages/disadvantages of PDD and how PDD can complement targeted approaches. Significantly, the conference will provide a much needed forum for the growing interest in PDD, and can conceivably become the cornerstone of the global scientific movement for the reintroduction of functional biology/physiology-driven pharmaceutical research.
Related subject(s)
54.
 
Oligo 2016
ID
740194
Start date
06 Apr 2016
Location
Oxford, United Kingdom
Abstract
We are delighted to announce our second Oxford Symposium on antisense and therapeutic oligonucleotides.  The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics.
Related subject(s)
55.
 
Manufacturing of Biologics and Biosimilars
ID
785636
Dates
14 Apr 2016 - 15 Apr 2016
Location
Munich, Germany
Contact
Andrea Weber;     Email: andrea.weber@fleming.events
56.
 
New Therapeutics for Diabetes and Obesity
ID
743958
Dates
17 Apr 2016 - 20 Apr 2016
Location
La Jolla, United States
Abstract
Type 2 diabetes (T2DM) is a global pandemic with approximately 350 million patients worldwide, driven largely by increasing prevalence of obesity. Multiple options exist for treatment of the primary disease and the array of associated cardiovascular disorders. Nonetheless, the majority of patients do not reach recommended glycemic goals, and there is an urgent need for more efficacious, cost-effective and safe therapies. The regulatory hurdle for new drugs is sizable and challenged by the specific requirement for cardiovascular mortality study. Given the magnitude of the challenges, highly collaborative efforts involving academia, biotech, pharma, regulatory agencies, patient advocacy groups and other key stakeholders are required to identify and advance new therapies that are substantially differentiated from current disease management. The major goals of this meeting are to: 1) Define the distance between current therapy relative to what is most needed to address successfully the near-term challenges of the disease and the wave of later-stage disease-specific complications; 2) Communicate the most important scientific advances in metabolic diseases with the intimate details that often escape peer-review publication and are seminal to drug R&D; and 3) Create opportunities for candid discussion among key stakeholders (academia, biotech, industry, regulatory, venture community, etc.) to identify new business processes, along with new science to streamline the successful conversion of ideas to medicines. Is it anticipated that the perspectives and science presented at this meeting, together with multiple platforms for discussion and interaction, will facilitate the identification of collaborations and opportunities for the discovery of transformative treatment of diabetes and related disorders. The meeting will be uniquely led by experienced drug-hunters with world-class academic credentials to help foster the translation of basic science to breakthrough therapeutics. We anticipate that this meeting will be of interest to a broad and diverse group of individuals interested in drug discovery and cost-effective development with an emphasis on quality, speed and value.
Related subject(s)
57.
 
3rd Annual Peptides Congress
ID
742845
Dates
18 Apr 2016 - 19 Apr 2016
Location
London, United Kingdom
Abstract
Oxford Global’s highly anticipated event offers a unique opportunity for over 400 biologics experts to discuss novel peptide research results and case studies in peptide therapeutics. Co-located with the highly established Proteins & Antibodies Congress and Biosimilars & Biobetters Congress.
Contact
Guillaume Alsonso;     Phone: [+44 (0)1865 248455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Peptide synthesis, Peptide manufacturing, Peptide development, Peptide research, Peptide technologies, Peptide applications, Peptide formulation, Peptide arrays, Peptide modification
58.
 
4th Annual Biosimilars & Biobetters Congress
ID
748132
Dates
18 Apr 2016 - 19 Apr 2016
Location
London, United Kingdom
Abstract
Oxford Global are proud to present our 4th Annual Biosimilars & Biobetters Congress, taking place on the 18th & 19th April 2016 in London. This exciting event will address key topics in development and commercial issues including emerging markets, regulation, interchangeability, and development case studies.
Contact
Danielle Dalby;     Phone: [+44 (0)1865 248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
biosimilars, biosimilar, biobetters, biobetter, biosuperiors, commercial affairs, clinical development, follow-on biologics, biologics development, strategic marketing, regulatory affairs, legal affairs, commercial development, medical affairs, market access, stability testing, trial design, biologics, generics, biologics manufacturing, strategy planning, quality assurance, clinical outsourcing, characterisation, extrapolation, assay development
59.
 
DCH — Drug Discovery Chemistry
ID
784849
Dates
19 Apr 2016 - 22 Apr 2016
Location
San Diego, California, United States
Abstract
Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program according to personal interests. New for 2016 will be the addition of three symposia on Friday covering the blood-brain barrier, biophysical approaches for drug discovery, and antivirals.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
drug discovery, drug development, chemistry, proteins, peptides, macrocyclics
60.
 
World Orphan Drug Congress USA 2016
ID
728969
Dates
20 Apr 2016 - 22 Apr 2016
Location
Washington, DC, United States
Abstract
This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. cademic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure.
Contact
Freya Smale;     Phone: [646-619-1811];     Email: freya.smale@terrapinn.com
Topics
In terms of content, people are talking more and more about gene therapy orphan drugs. 2016 will feature the latest content on gene therapy orphan drugs in development. The other new addition to 2016 is a workshop for clinicians. This workshop is designed to enable marketers to help clinicians get educated on rare diseases and orphan drugs so they can detect and diagnose rare diseases better and faster.
61.
 
8th International Congress of Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology
ID
745884
Dates
20 Apr 2016 - 24 Apr 2016
Location
Antalya, Turkey
Related subject(s)
62.
 
CPhI CAPA & Root Cause Investigation Workshop
ID
782951
Dates
21 Apr 2016 - 22 Apr 2016
Location
Mumbai, India
Abstract
CPhI's CAPA & Root Cause Investigation Workshop is the only forum in India dedicated to identifying non-compliance, understanding the root cause, and responding with appropriate corrective and preventive actions for the Pharmaceutical companies. It is an exclusive workshop mentored by Former USFDA Director on areas of quality and manufacturing in Pharma companies with focus on USFD's Quality System Guide, recent Warning Letters and EU-GMP Chapter 1 regulations.
Contact
Purvai Gupta;     Phone: [+91-22-61727077];     Email: purvai.gupta@gmail.com
Topics
CAPA, Root Cause Analysis, Quality Management System, Quality, warning letter, corrective action, Pharma warning letters, 483s, Corrective action preventive action, deviation management, signal detection,
63.
 
Pharmaceutics-2016 — World Congress & Expo on Pharmaceutics & Drug Delivery Systems
ID
766134
Dates
21 Apr 2016 - 23 Apr 2016
Location
Dubai, United Arab Emirates
Contact
Varun;     Phone: [7799790001];     Email: pharma.congress@scientificfederation.com
Topics
Recent Innovations in Drug delivery technology, Drug Targeting, Nanotechnology in Drug Delivery Systems, Drug discovery and medicinal chemistry, Physiological Considerations of Drug Delivery, Advances in Biotherapeutics-Drug Discovery and Development
64.
 
Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity
ID
738394
Dates
21 Apr 2016 - 25 Apr 2016
Location
Varadero, Cuba
Abstract
The four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of disease pathogenesis and new targeted therapies development for Cancer and for Autoimmune Disorders. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research.

One of the key objectives of the 2016 Symposium will be to arm delegates with the necessary tools that will enable them to make a difference, implement and take actions at all levels, in global fight against cancer or autoimmunity diseases.

Contact
Jesus Benitez;     Email: biomed@cigb.edu.cu
Topics
Molecular oncology; Tumor immunology; Cancer Immunotherapy, Clinical trials; Mechanisms of autoimmune-related diseases; Regulatory T cells and autoimmunity; Pharmacological strategies for treatment
Related subject(s)
65.
 
Stem Cell Research & Regenerative Medicine Conference
ID
744954
Dates
25 Apr 2016 - 26 Apr 2016
Location
Boston, United States
Abstract
This conference presents information regarding cutting-edge developments in all areas of stem cell research, including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.
66.
 
Pre-Filled Syringes East Coast
ID
770721
Dates
25 Apr 2016 - 26 Apr 2016
Location
Iseline, New Jersey, United States
Abstract
Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a focal point to discuss the latest innovations and developments in pre-filled syringes; as well as honing in on industry challenges and regulatory compliance.
Contact
Teri Arri;     Phone: [+44 (0)20 7827 6000];     Email: tarri@smi-online.co.uk
Topics
prefilled syringes, autoinjectors, human factors, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, injectable devices, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, manufacturing, medical device, parenteral drug, plastics, quality by design
67.
 
Stem Cell Summit
ID
744986
Dates
25 Apr 2016 - 27 Apr 2016
Location
Boston, United States
Abstract
Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
68.
 
2016 Diabetes Summit — 2016 Diabetes Summit
ID
766526
Dates
25 Apr 2016 - 27 Apr 2016
Location
Boston, United States
Abstract
GTCbio and the advisory board would like to invite you to the 2016 Diabetes Summit to be held April 25-27, 2016 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently: 9th Diabetes Drug Discovery & Development Conference & 6th Diabetes Partnering & Deal-Making Conference.
Contact
Kristen Starkey;     Phone: [16262566405];     Email: infogtcbio@gtcbio.com
Related subject(s)
69.
 
Lyophilization USA
ID
781488
Dates
27 Apr 2016 - 28 Apr 2016
Location
Iselin, United States
Abstract
Lyophilization USA 2016 will gather leading market experts to discuss the latest cutting edge developments in freeze drying as well as solutions to on-going industry challenges. The packed agenda features a mix of case study led presentations, panel debates, interactive workshops and keynote addresses that have been tailored for an audience of professionals working in pharmaceutical lyophilization from formulation development through to production and quality assurance. Featured Speakers include Pfizer, Genzyme, Allergan, Novo Nordisk A / S, Johnson & Johnson, Steritech Solutions LLC, Biogen Idec, Momenta Pharmaceuticals, PLUS MANY MORE!
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral
70.
 
Malaria Vaccines for the World MVW 2016
ID
758837
Dates
02 May 2016 - 04 May 2016
Location
Leiden, Netherlands
Abstract
With more an estimated 200 million clinical cases annually, resulting in more than 580,000 deaths, malaria is not only an important global health problem but also a major factor limiting economic development in developing countries. Interventions that deploy an effective malaria vaccine are regarded as being one of the most cost-effective and reliable means to limit and ultimately eradicate the disease. In recent years, due to increased funding and research, malaria vaccine development has greatly accelerated. The MVW 2016 conference will look at different aspects of vaccine development, assessment and deployment, as well as funding and regulatory aspects of vaccine implementation and testing. The conference will also highlight research on the use of animal models and (controlled) clinical trials to study the immunological basis of protection and to identify novel candidate vaccine antigens.
Related subject(s)
71.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance Course
ID
722675
Dates
09 May 2016 - 13 May 2016
Location
Oxford, United Kingdom
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
72.
 
10th Drug Design & Medicinal Chemistry Conference
ID
765180
Dates
11 May 2016 - 12 May 2016
Location
Berlin, Germany
Abstract
We are excited to announce the 10th Drug Design & Medicinal Chemistry Conference, to be held May 11-12, 2016 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape of drug discovery in emerging target classes and chemical biology approaches for discovering new medicines. Leaders in the field will present on hot topics such as protein-protein interactions, overcoming resistance in drug design, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.
Contact
Kristen Starkey;     Phone: [626-256-6405];     Email: infogtcbio@gtcbio.com
Topics
Drug Design, Medicinal Chemistry
73.
 
3rd 3D Models & Drug Screening Conference
ID
787007
Dates
11 May 2016 - 12 May 2016
Location
Berlin, Germany
Abstract
GTCbio is proud to present the 3rd 3D Models & Drug Screening Conference, to be held on May 11-12, 2016 in Berlin, Germany.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
74.
 
European Pharma Summit 2016
ID
787017
Dates
11 May 2016 - 13 May 2016
Location
Berlin, Germany
Abstract
We invite you to attend the European Pharma Summit 2016, which will take place on May 11-13, 2016 in Berlin, Germany.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
75.
 
3rd GPCR Targeted Screening Conference
ID
787049
Dates
12 May 2016 - 13 May 2016
Location
Berlin, Germany
Abstract
We invite you to attend the 3rd GPCR Targeted Screening Conference, which will take place on May 12-13, 2016 in Berlin, Germany.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
GPCR, Targeted, Screening
76.
 
VI EWDSy — Sixth European Workshop in Drug Synthesis
ID
780027
Dates
15 May 2016 - 19 May 2016
Location
Siena, Italy
Contact
Email: ewdsy.siena@gmail.com
Topics
drug synthesis, HIV, neglected diseases, ADMET, toxicology, organic chemistry, catalysis
Event website
77.
 
2nd Annual Formulation & Drug Delivery Congress 2016
ID
748317
Dates
18 May 2016 - 19 May 2016
Location
London, United Kingdom
Abstract
Oxford Global are delighted to announce the 2nd Annual Formulation & Drug Delivery Congress, 18 – 19 May 2016, London, UK. Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss over 40 presentations and case studies focused on the key issues in biologics and small molecule drug formulation and delivery.
Contact
Guillaume Alonso;     Phone: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Biologics, Formulation, Drug Delivery, Biologics, Small Molecule, Nanoparicle,
78.
 
Modern Vaccines/Adjuvants Formulation MVAF 2016
ID
758849
Dates
18 May 2016 - 20 May 2016
Location
Copenhagen, Denmark
Abstract
The increasing need for new and improved vaccines and the growing level of sophistication of their associated adjuvantation and delivery systems has major implications for the design, formulation, delivery, manufacturing and quality assessment of modern vaccines and immune interventions in general. MVAF 2016 will be the fifth meeting in this successful series and again will offer an international forum for the discussion of all aspects of vaccine and adjuvant formulation and will focus on: Innovation in vaccine design and adjuvantation/delivery technologies Challenges to manufacturing and the administration of modern vaccines Compliance with quality standards and regulatory requirements MVAF 2016 will then assess the impact of all of the above on the future development/design of vaccines and adjuvants.
Related subject(s)
79.
 
Molecular Diagnostics World Summit 2016
ID
759009
Dates
19 May 2016 - 20 May 2016
Location
London, United Kingdom
Abstract
The global molecular diagnostics market is predicted to reach $8 billion by 2018. This market is highly influenced by the raise of infectious diseases such as TB, HIV etc, antimicrobial resistance and other factors. 80% of the market are shared between Europe and America and remaining 20% between Rest of the World. To provide efficient treatment and disease management there is an urgent need for rapid and more efficient diagnostics. In terms of technology PCR based diagnostics are rapidly growing and possess the major market shares. NGS, POC, Microarrays and others form the rest of the market. Molecular Diagnostics market comprises of instruments, reagents, software and end user services which has a great future and growth by 2018. Thus, Molecular Diagnostics World Summit 2016, conference offers a rare opportunity to its participants to understand and learn from top experts in the Molecular Microbiology and Diagnostics field and to share ideas and develop new business collaborations. The conference will also provide a platform to discuss the current vital issues, market assessment, commercialization and globalization.
Related subject(s)
80.
 
New Approaches to Vaccines for Human and Veterinary Tropical Diseases
ID
743978
Dates
22 May 2016 - 26 May 2016
Location
Cape Town, South Africa
Abstract
Human and livestock vaccines can contribute to improved human welfare and income generation by maintaining human health and meeting the demand for meat, milk and fish in developing countries. All of these factors contribute to the growing importance of improving food safety, availability and nutritional security. An important component of this Keystone Symposia meeting will be to stimulate crosstalk between the human and veterinary vaccine communities by highlighting cross-cutting technical advances and new science and knowledge from laboratory and field research. The meeting will also provide a rare opportunity for scientists from the Northern and Southern hemispheres to interact and pool resources and knowledge in the common fight against tropical diseases.
81.
 
3rd NovAliX Conference - Biophysics in Drug Discovery 2016
ID
788796
Dates
07 Jun 2016 - 10 Jun 2016
Location
Strasbourg, France
82.
 
ECI — Vaccine Technology VI
ID
738458
Dates
12 Jun 2016 - 17 Jun 2016
Location
Cetraro, Calabria, Italy
Abstract
This conference series addresses technical and scientific issues in the development and manufacturing of vaccines. It will also discuss broader issues related to vaccine development and access that will be of interest to institutional and academic participants. Emphasis will be particularly placed on emerging diseases and developing world.
Contact
Arlene Conway;     Phone: [212 514 6760];     Email: info@rngconfintl.org
Topics
Break through developments in vaccinology •Issues and case studies in process development •Formulating and delivering vaccines •Vaccine characterization/analytics •Therapeutic vaccines •Case studies •New challenges, new technologies in vaccine development. •One world, one health
83.
 
Vaccine Technology VI
ID
721644
Dates
12 Jun 2016 - 17 Jun 2016
Location
Albufeira, Portugal
Contact
ARLENE CONWAY;     Phone: [2125146760];     Email: info@engconfintl.org
Topics
In line with previous years, session topics will focus on all aspects of vaccine technology. This will include: •early antigen discovery and design •process development •analytics •clinical trials •commercialization.
84.
 
17th Annual Drug Discovery Leaders Summit 2016
ID
773991
Dates
13 Jun 2016 - 14 Jun 2016
Location
Berlin, Germany
Abstract
Oxford Global’s 17th Annual Drug Discovery Leaders Summit and our co-located 4th Annual Discovery Chemistry and Drug Design Congress is Europe’s leading Summit in the drug discovery and discovery chemistry field. Our prestigious Summit brings together prominent decision makers working at the forefront of research into target based discovery, phenotypic screening, medicinal chemistry and drug design.
Contact
Guillaume Alonso;     Phone: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Target Based Discovery, Screening and Assays: Enabling Technologies, Novel Therapeutic Modalities, Supporting Innovation: Data and Information Management, Discovery Chemistry: Latest Case Studies, Drug Design: Novel Approaches, Large Molecule Discovery Approaches
85.
 
6th RSC / SCI symposium on GPCRs in Medicinal Chemistry
ID
740279
Dates
13 Jun 2016 - 15 Jun 2016
Location
Verona, Italy
Abstract
The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
86.
 
Clinical Quality & Compliance Masterclass
ID
785659
Dates
16 Jun 2016 - 17 Jun 2016
Location
Vienna, Austria
Contact
Andrea Weber;     Email: andrea.weber@fleming.events
Topics
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
Related subject(s)
87.
 
Clinical Quality & Compliance Masterclass
ID
785605
Dates
16 Jun 2016 - 17 Jun 2016
Location
Amsterdam, Netherlands
Contact
Andrea Weber;     Email: andrea.weber@fleming.events
Topics
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
Related subject(s)
88.
 
CMS3 — Advanced Topics on Cell Model Systems
ID
789629
Dates
20 Jun 2016 - 24 Jun 2016
Location
Rome, Italy
Abstract
An intensive one week laboratory and lecturer school for PhD students and young researchers in the Eternal City Rome to facilitate an effective sharing and dissemination of new and innovative research ideas, strategies, focal points on cell model systems to promote pharmaceutical, pharmacogenomics, tissue engineering and computational research together with twelve outstanding scientists from different countries: Germany, Israel, Italy, Switzerland, United Kingdom. Fiftheen scientists of the Research Establishment of National Research Council (CNR) will impart practical exercises at laboratories on techniques in model membrane systems, optical microscopy, Raman and IR spectroscopy, nanostructures and biosensors, and dynamic molecular simulation. No other schools are present in Europe on this specific topic and mixing of theoretical and practical approaches.The school is certified as UNI EN ISO 9001:2000. The management respects the standard procedure and quality of international level. Participants must have a degree in either: Physics, Mathematics, Chemistry, Engineering, Biology or Medicine and a basic working knowledge of experimental research. Preference will be given to Ph.D. students and junior scientists under 35 and to those having not more then five years research experience. Applicants should send their current CV to the School Secretariat by email to: cms3.cnr@gmail.com , together with a formal signed letter of recommendation from a Professor who is aware of their work. The CV should include details of academic qualifications and a list of scientific publications as well as a short description of their current scientific research. Closing date for applications: May 6th, 2016. Registration fee:150 eur per person. It includes all academic sessions, course material, daily coffee-break and lunch (without drinks), social programme and certificate of completation.
Contact
Alfonsina Ramundo Orlando;     Phone: [+39 (0)6 45488213];     Email: cms3.cnr@gmail.com
Topics
Cell model systems, Biophysics, Pharmacology, Imaging, Bio-sensors, Molecular Dynamic Simulations
Related subject(s)
Event website
89.
 
Pharmacovigilance Europe 2016
ID
759873
Dates
21 Jun 2016 - 22 Jun 2016
Location
London, United Kingdom
Abstract
The  Pharmacovigilance Europe 2016  conference will participants an opportunity and a platform to share experiences with the likeminded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.
90.
 
5th Annual Drug Repositioning, Repurposing and Rescue Conference
ID
759860
Dates
21 Jun 2016 - 22 Jun 2016
Location
Chicago, United States
91.
 
International Scientific Conference on Probiotics and Prebiotics - IPC2016
ID
745896
Dates
21 Jun 2016 - 23 Jun 2016
Location
Budapest, Hungary
Abstract
IPC2016 is the biggest scientific conference worldwide, solely focusing on probiotics and prebiotics for scientists, researchers, product developers, industry participants, pharmaceutical, medical, health and regulatory professionals as well as venture capitalists and investors.  The aim of the conference is to learn about recent advances, likely future developments and to exchange scientific ideas and experiences in our field – all within a unique environment. It is our intention to further confirm IPC as the leading scientific conference on probiotics and prebiotics. Every year the conference attracts up to  500 leading scientists,  opinion leaders, clinical study managers, medical doctors and dietitians from  more than 80 countries.
92.
 
Virus-Like Particle & Nano-Particle Vaccines VLPNPV 2016
ID
760078
Dates
22 Jun 2016 - 24 Jun 2016
Location
Leiden, Netherlands
Abstract
Virus-like particles are supra-molecular assemblages incorporating key immunologic features of viruses which include repetitive surfaces, particulate structures with potential for induction of innate immunity through activation of pathogen-associated molecular-pattern recognition receptors. They carry no replicative genetic information and can be produced in heterologous expression systems at large scale. Virus-like particles thus represent a safe and effective vaccine platform with potential to induce potent B- and T-cell responses. In addition to being effective vaccines against the corresponding viruses from which they are derived, virus-like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, virus-like particles have been used to induce auto-antibodies to disease-associated self-molecules involved in chronic diseases, such as hypertension and Alzheimer’s disease. The recognition of the potent immunogenicity and commercial potential for virus-like particles has greatly accelerated research and development activities. During the last decade, two prophylactic virus-like particle vaccines have been registered for human use, while another 12 vaccines entered clinical development. VLPNPV 2016 is the third meeting in this new series for international researchers working on Virus-Like Particles (VLPs) and Nano-Particle Vaccines (NPVs).
93.
 
RICT 2016 — Interfacing Chemical Biology and Drug Discovery
ID
788767
Dates
06 Jul 2016 - 09 Jul 2016
Location
Caen, France
Event website
94.
 
Asia-Pacific Pharma Congress
ID
726880
Dates
14 Jul 2016 - 16 Jul 2016
Location
Kuala Lumpur, Malaysia
Abstract
Asia Pharma-2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.Asia Pharma-2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals. So, all are whole heartedly invited to be a part of this conference.
Contact
Robert Brown;     Phone: [1-650-268-9744];     Email: asiapharma@pharmaceuticalconferences.com
Topics
IPR and Regulatory Affairs, Pharmacognosy, Pharmaceutics, Nanotechnology, Industrial Pharmacy, Pharmacology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Hospital and Clinical Pharmacy.
95.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786104
Dates
24 Jul 2016 - 29 Jul 2016
Location
Big Sky, Montana, United States
Abstract
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: SRC@faseb.org
Related subject(s)
96.
 
IIR-cryobio-workshop — IIR Workshop on Cold Applications in Life Sciences
ID
789032
Dates
08 Sep 2016 - 09 Sep 2016
Location
Dresden, Germany
Abstract
Cell/tissue cryopreservation and cold storage are central challenges e.g. in biobanking. Freezing and cryoprocessing are becoming increasingly important as an essential production step in life sciences, too.
Contact
Dr. Gabriele Spoerl;     Phone: [+49 351 4081 604];     Email: gabriele.spoerl@ilkdresden.de; CryoWorkshop2016@ilkdresden.de
Topics
Cell/tissue cryopreservation and storage challenges: advanced devices for cryopreservation and freeze-drying, cryobanking of biologicals, 3D-scaffolds / tissue engineering for medical and diagnostic applications, strategies with alternative cryoprotectants for tissues cryopreservation, industrial solutions in biomaterial processing. Freezing and storage of active agents for in-vitro and in-vivo applications: damage processes on active agents caused by cold application, process limitations and impact factors on product stability, process validation – analytics, monitoring and simulation of process and product loss, vitrification of cellular products without cryoprotectants, industrial freezing solutions - large scale and multi-product plant.
Related subject(s)
97.
 
MUCOVAD 2016 — Mucosal Vaccines, Adjuvants & Delivery
ID
762133
Dates
14 Sep 2016 - 16 Sep 2016
Location
Lausanne, Switzerland
Abstract
MUCOVAD 2016 will be an opportunity for researchers to hear updates on new developments in the area of mucosal vaccines and associated adjuvantation and delivery mechanisms/platforms
98.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776909
Dates
26 Sep 2016 - 27 Sep 2016
Location
The Royal Society at Chicheley Hall, Buckinghamshi, United Kingdom
Abstract
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Contact
Naomi Asantewa-Sechereh;     Phone: [+442074512515];     Email: kavli.events@royalsociety.org
Topics
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Related subject(s)
99.
 
14th Annual Pharma IT Congress
ID
787558
Dates
28 Sep 2016 - 29 Sep 2016
Location
London, United Kingdom
Abstract
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Contact
Guillaume Alonso;     Phone: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Related subject(s)
100.
 
ICONAN 2016 — International Conference On Nanomedicine And Nanobiotechnology
ID
785189
Dates
28 Sep 2016 - 30 Sep 2016
Location
Paris, France
Abstract
The target is to set up one of the most attractive international annual gatherings of experts from all around the world, in order for them to exchange about their latest research results and share their ideas.
Contact
ICONAN 2016 Organizing Committee;     Phone: [0033781201182];     Email: iconan2016@premc.org
Topics
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobisystems, Microfluidics in nanomedicine and nanobiology.
Related subject(s)
101.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749615
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
Topics
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
102.
 
GCC Pharma Congress
ID
773501
Dates
17 Oct 2016 - 20 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
103.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788248
Dates
17 Nov 2016 - 20 Nov 2016
Location
Singapore, Singapore
Abstract
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Contact
Conference Secretariat;     Phone: [+65 6570 6280];     Email: info@apamt2016.com
Topics
Toxicology Poison Analysis Chemical Environmental Toxinology
104.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773728
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Related subject(s)
105.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789658
Dates
29 Nov 2016 - 30 Nov 2016
Location
Munich, Germany
Abstract
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Contact
BioM Biotech Cluster Development GmbH;     Phone: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Topics
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
Event website
106.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781802
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)
LYOPHILIZATION USA
PAIN THERAPEUTICS
RNA Therapeutics
Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success
Pre-Filled Syringes East Coast

Good to know...

You can advertise your event or services in this space.

Last updated: 30 October 2092